Diabeloop
PrivateLast Round
Series C
Extension
Mar 4, 2024
Total Funding Raised
$143.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Diabeloop is a medical technology company that develops artificial intelligence-based solutions to automate and personalize the treatment of diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diabeloop Comparables
Compare Diabeloop with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CamDiab Ltd | 89% | |
| Beta Bionics | 82% | |
| Inreda Diabetic B.V. | 81% |
Diabeloop Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Mar 4, 2024 | ||||
| Series C | Jun 2, 2022 | ||||
| Debt | Jun 2, 2022 | ||||
| Grant | Mar 31, 2021 | ||||
| Series B | Dec 2, 2019 | ||||
Grant | Nov 1, 2018 |
Key People
Founding team and executive leadership
Diabeloop Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Odyssée Venture | Series B, Series C |
| European Innovation Council Fund | Grant |
| Kreaxi | Series B, Series A, Series C |
| Sofimac Innovation | Series B |
| Innovacom | Series C |
| Supernova Invest | Series B, Series A, Series C |
| Air Liquide Venture Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
Surpassed 10,000 users for its DBLG1 System.
- Mar 10, 2026
Equipped over 10,000 people since 2021 launch.
Recent news
Latest coverage and updates
- launchesJul 10, 2026
Diabeloop SA launched DBLG2 Automated Insulin Delivery system on Jul 10th '26.
Diabeloop Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Diabeloop's valuation, stock price, and market status.
Is Diabeloop a public or private company?
Diabeloop is a private company.
What is the current stock price of Diabeloop?
Diabeloop is a private company with no public stock price. No recent secondary market data is available.
How much is Diabeloop worth (valuation)?
Valuation information for Diabeloop is not publicly available.
Can I buy Diabeloop stock?
Diabeloop shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Diabeloop's last funding round?
Diabeloop's most recent funding round was Series C Extension on March 26, 2024.
Who are the main investors in Diabeloop?
Key investors in Diabeloop include Cemag Invest, LBO France.
Will Diabeloop IPO soon?
No public IPO plans have been announced for Diabeloop.
How can I track Diabeloop secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Diabeloop's secondary market activity and sign up for updates.